The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types
© Abdulamir et al; licensee BioMed Central Ltd. 2008
Received: 25 August 2008
Accepted: 05 December 2008
Published: 05 December 2008
Nasopharyngeal carcinoma (NPC) and other head and neck cancer (HNCA) types show a great epidemiological variation in different regions of the world. NPC has multifactorial etiology and many interacting risk factors are involved in NPC development mainly Epstein Barr virus (EBV). There is a need to scrutinize the complicated network of risk factors affecting NPC and how far they are different from that of other HNCA types.
122 HNCA patients and 100 control subjects were studied in the region of the Middle East. Three types of HNCA were involved in our study, NPC, carcinoma of larynx (CL), and hypopharyngeal carcinoma (HPC). The risk factors studied were the level of EBV serum IgG and IgA antibodies measured by ELISA, age, sex, smoking, alcohol intake, histology, and family history of the disease.
EBV serum level of IgG and IgA antibodies was higher in NPC than CL, HPC, and control groups (p < 0.01). NPC was associated with lymphoepithelioma (LE) tumors, males, regular alcohol intake, and regular smoking while CL and HPC were not (p < 0.05). CL and HPC were associated with SCC tumors (p < 0.05). Furthermore, NPC, unlike CL and HPC groups, was not affected by the positive family history of HNCA (p > 0.05). The serum levels of EBV IgG and IgA antibodies were higher in LE tumors, regular smokers, younger patients, and negative family history groups of NPC patients than SCC tumors, non-regular smokers, older patients and positive family history groups respectively (p < 0.05) while this was not found in the regular alcoholics (p > 0.05).
It was concluded that risk factors of NPC deviate much from that of other HNCA. EBV, smoking, alcohol intake, LE tumors, male patient, and age > 54 years were hot risk factors of NPC while SCC and positive family history of the disease were not. Earlier incidence, smoking, LE tumors, and negative family history of the disease in NPC patients were associated much clearly with EBV. It is proposed that determining the correct risk factors of NPC is vital in assigning the correct risk groups of NPC which helps the early detection and screening of NPC.
Nasopharyngeal carcinoma (NPC) was shown to be distinct from other head and neck cancer (HNCA) types in terms of histopathological spectrum, and geographical distribution . In the Western world, NPC is an uncommon type of tumor. In the USA, NPC represents less than 1% of all cancers. The annual incidence in the USA and Europe varies between 0.22 and 0.5 per 100 000 population [2, 3]. In contrast, NPC is widely prevalent in South East Asia, the Middle East, and North Africa where higher incidence of NPC has been reported than other parts of the world [4, 5]. However, China and Southeast Asian countries have been considered as the highest incidence regions for NPC in the world where incidence could reach 20 to 50 per 100 000 individuals [4–8]. Nevertheless, high NPC incidence rate, 92/100,000 was found in some parts of the Middle East in 2002–2003 . These figures are surprisingly higher than that in China and South East Asia making the Middle East region as one of the highly endemic regions for NPC. Unfortunately, the high incidence of NPC in this region has long been underestimated. Moreover, the risk factors of NPC development have not been studied thoroughly in this region of the world.
NPC is highly metastatic and invasive malignant tumor. Approximately 90% of NPC patients show malignant cervical lymph nodes . Epstein-Barr virus (EBV) is considered as one of the main etiological factors of NPC, which is an oncogenic herpesvirus associated with a variety of malignancies in T cells, B cells, and epithelial cells . EBV establishes a life-long persistent infection in over 90% of the human adult population worldwide . EBV has been linked to the development of a variety of human malignancies of lymphoid and epithelial origin, including Burkitts lymphoma, Hodgkin's lymphoma, and NPC .
In this study, NPC patients were the core group for the comparison with other HNCA patients in terms of the studied risk factors namely, age, sex, staging of the disease, histology of the tumors, smoking, alcohol intake, family history of the disease, and EBV serology. The aim of this study was to evaluate precisely the essential risk factors and assign correctly the high risk groups of NPC and other HNCA types in the population of the Middle East where a remarkable shortage of research has been present.
The population of the study
One hundred twenty two HNCA patients were selected without any bias to any type during the period between January 2006 to January 2008 in the University hospital of the Medical College of Alnahrain University and Radiotherapy Reference Center in Baghdad, Iraq, and from Alhussein Hospital in Amman, Jordan. The samples were processed and the study was totally conducted in University Putra Malaysia (UPM). HNCA patients were involved after the diagnosis was established. Primary HNCA cases were selected rather than secondary or recurrent cases. HNCA patients were 42 NPC patients, 66 carcinoma of larynx (CL), and 14 hypopharyngeal carcinoma (HPC) patients. HNCA patients and control subjects in Iraq and Jordan were native Middle Eastern people of Arabic ethnicity. Twenty patients of other HNCA types that were of small sample size, less than 6 patients, were neglected for statistical purposes such as tongue, retromalar, tonsillar, epiglottic and post-pharyngeal carcinomas. The age of HNCA patients ranged between 16 to 74 years old, median, 53 years and mean 51.8 years. The median age of NPC patients was 54.4 years and the mean age was 54 years. For HPC patients, the median age was 62.5 years and the mean age was 62.16 years. For CL patients, the median age was 50.5 years and the mean age was 50.81 years. HNCA patients were 89 (72.9%) males and 33 (27%) females at male:female ratio, 2.6:1. NPC patients were 9 (21.4%) females and 33 (78.5%) males revealing male predominance at sex ratio, 3.6:1. HPC patients were 12 (85.7%) females and 2 (14.3%) males with females predominance at sex ratio 1:6. CL patients were 6 (9%) females and 60 (91%) males with clear male predominance at sex ratio 10:1. HNCA staging was based on TNM system by which HNCA patients were classified into 4 stages, depending on T (the extent of primary tumor), N (regional LN spread) and M (distant metastasis) . Accordingly, the studied HNCA patients were diagnosed at different stages of the disease, 68% at stage IV, 21% at stage III, 7% at stage II, and 4% at stage I.
One hundred age- and sex- matched control subjects were selected. Control subjects were those who attended hospitals for minor traumatic therapy. They showed normal blood and biochemical laboratory tests, namely differential blood count, hemoglobin level, total serum proteins, liver function tests, erythrocytes sedimentation rate, kidney function tests, and C-reactive proteins as well as were medically tested by a specialist and found free of HNCA or any other medical illness.
The survey data and sampling
Direct interview was done with HNCA patients. The data sheet for survey encompassed name, age, sex, smoking, the number of smoked cigarettes per day, how many years the smoking habit has been, alcohol consumption, level and duration of alcohol consumption, the type of alcohol drink, the family history of HNCA (parents, brothers/sisters, cousins and children). Moreover, the past and recent medical records and the reports of histopathology of the involved patients were reviewed. The cutoff line of regular smoking (smoking > 10 cigarettes per day more than 10 years) was used in this study. In terms of Brinkman index, number of cigarettes smoked per day multiplied by number of years of smoking, this cutoff line is equal to 100. The cutoff line for regular alcohol consumption is equal to or more than 2 glasses per day (about 400–500 mL/day) of drinks with alcohol concentration more than 12% for 10 years and more. This is equal to ethanol consumption > 210 g/week for more than 10 years. Above this cutoff value, individuals were considered regular alcoholics .
Sera were sampled from HNCA patients before the beginning of chemotherapy or surgery and from control subjects after excluding any HNCA and other medical illness. Sera were used to estimate the serum level of EBV IgG and IgA antibodies via ELISA. After surgery, paraffin embedded sections were retrieved from the excisional biopsies of HNCA primary tumors. The histopathological examination and classification was carried out by a histologist. The histopathology of HNCA tumor sections was assessed and classified for purposes of comparison into two main groups; well-differentiated squamous cell carcinoma (SCC) and undifferentiated lymphoepithelioma (LE). Written consents were granted by HNCA patients and control subjects. The procedures of specimens sampling and patient interviewing were done according to the guidelines of Helsinki declaration for the ethics of the biomedical research. Official permission was granted by the regional Ethics committee of medical research in Baghdad and Amman clinical institutes.
ELISA for Epstein Barr virus serum antigens
EBV viral capsid antigen (VCA) (Wellcome) was used for coating the solid phase of 96 wells microtiter plates. The antigen was diluted 1:10 in carbonate-bicarbonate coating buffer (1.59 g/L carbonate & 2.93 g/L bicarbonate) (Sigma). After a series of standardization steps, 50 μl/well of the EBV antigen in coating buffer were added for overnight at 4°C. Next day, the remaining fluid was aspirated and wells were washed twice with washing buffer (PBS from Sigma, 1% BSA w/v from Merck, 0.05% v/v Tween 20 from Merck). Blocking buffer (PBS, 1% BSA w/v) was then added for 1 hour. After washing step, 50 ul/well of non-diluted serum of HNCA patients and control subjects were added in duplicates. The ELISA plate was incubated for 2 hours at 37°C. Two sets of ELISA were pursued, the first for detecting EBV serum IgG antibodies and the second for detecting EBV serum IgA antibodies. After washing step, 50 ul/well of horseradish peroxidase-labeled rabbit anti-human IgG and IgA antibodies were added at 1:40 and 1:100 dilution respectively of original concentration 2 mg/mL for anti-human IgG and 3 mg/mL for anti-human IgA (ICN immunologicals). After washing step, 50 ul of the chromogen-substrate, OPD-H2O2, (Sanofi diagnostics) were added and incubated for 15 minutes for the development of the enzymatic reaction of horseradish peroxidase. ELISA readings in terms of optical density (OD) were measured immediately by microplate reader A-1764A (Beckman) at wavelength of 492 nm . Duplicate wells of negative control, distilled water instead of serum, and duplicate wells of positive control solutions (Wellcome) at standardized working concentration, 10 ug/mL of EBV VCA antigen, were used at each run of ELISA. Since ELISA was used for measuring the burden of EBV serum IgG and IgA antibodies for comparative purposes among the studied risk factor groups of HNCA patients, no cutoff value was needed for demarcating sera into seronegative or seropositive nor calibration curve was needed to measure the real concentration of antigens.
The statistical analysis was preformed using software Statistica version 6.1.478.0 and MS Excel 2000. ELISA OD values were presented as mean ± 2 standard error. After confirming the normal distribution pattern of ELISA values by Kolmogorov and Smirnov tests, parametric multivariate student t-tests were used to evaluate the significance of difference among the mean ELISA OD readings for EBV serum IgG and IgA antibodies. For qualitative categorized data (number of subjects showing certain event), the significance of association was measured by applying Chi square test of independence for contingency tables and corrected by Fishers' Exact test when needed. The histograms used for ELISA OD mean values were shown with error bars and p values of significant difference, while histograms of observational data, number of subjects and their parentages, were not shown with p values and error bars as chi square test for independence measures the significant association of variables' frequency rather than the significant difference of the variables' values.
Serum level of EBV IgG and IgA antibodies
The mean ± 2 standard error of ELISA OD readings of EBV serum IgG and IgA antibodies in control, HNCA, NPC, CL, and HPC groups
Mean ELISA OD EBV serum IgG
Mean ELISA OD EBV serum IgA
0.13 ± 0.018
0.094 ± 0.007
0.165 ± 0.02
0.175 ± 0.09
0.352 ± 0.045
0.453 ± 0.08
0.132 ± 0.009
0.1 ± 0.04
0.126 ± 0.01
0.11 ± 0.03
The histological characteristics of HNCA patients
The number and percentage of patients/subjects with the studied observations of this study in control, NPC, CL, and HPC groups
Histopathology of tumors:
Regular alcohol consumers
SCC in the regular alcohol consumers
SCC in the non-regular alcohol consumers
HNCA-positive family history
The mean ± 2 standard error of ELISA OD readings of EBV serum IgG and IgA antibodies in different subgroups of NPC and CL patients
Mean ELISA OD EBV serum IgG
Mean ELISA OD EBV serum IgA
NPC patients with LE
0.397 ± 0.036
0.527 ± 0.076
NPC patients with SCC
0.239 ± 0.067
0.268 ± 0.09
CL patients with LE
0.135 ± 0.01
0.11 ± 0.032
CL patients with SCC
0.131 ± 0.008
0.093 ± 0.044
Below-median age group of NPC
0.314 ± 0.039
0.486 ± 0.073
Above-median age group of NPC
0.327 ± 0.047
0.3 ± 0.082
Regular smokers in NPC
0.379 ± 0.043
0.493 ± 0.084
Non- regular smokers in NPC
0.19 ± 0.057
0.213 ± 0.056
Regular alcohol consumers in NPC
0.325 ± 0.05
0.466 ± 0.072
Non-regular alcohol consumers in NPC
0.372 ± 0.041
0.445 ± 0.086
HNCA-positive family history group of NPC
0.2 ± 0.065
0.177 ± 0.1
HNCA-negative family history group of NPC
0.377 ± 0.041
0.499 ± 0.076
Age and Sex factors in HNCA patients
It was shown that sex ratio in HNCA groups was significantly different from each other (p < 0.01) in that HPC group showed the lowest male:female ratio, 1:6, then NPC, 3.6:1 and the highest ratio was found in CL, 10:1. On the other hand, sex of NPC patients did not show a significant association with EBV serum antibodies (p > 0.05) like that shown in the age of NPC patients. There was no association between sex ratio and age of patients and staging of the disease (p > 0.05).
Positive family history of the disease
This study explored the complicated network of risk factors of NPC and other types of HNCA in one of the highly NPC-endemic regions in the world, the Middle East. The role of EBV as a risk factor of NPC was the pivotal line of research that all other risk factors were linked to. The strategy of this research was comparing the studied risk factors in; HNCA patients as one group versus control subjects and different HNCA groups versus control subjects and with each other. Moreover, it was aimed at comparing EBV serum level of IgG and IgA antibodies in different subgroups of NPC patients.
NPC patients showed the highest level of serum EBV IgG and IgA antibodies when compared to the studied HNCA groups and control group. This is in agreement with many published reports that explored the association between EBV and HNCA in general and NPC in particular [17–20]. Elevated antibody titers to EBV antigens, e.g. early antigens, viral capsid antigens are frequently found in NPC patients and have been considered as important markers in the diagnosis and prognosis of these EBV-associated diseases [17, 18]. It's a special feature of NPC that patients sustain high levels of a broad spectrum of EBV antibodies especially those for IgA and IgG subtypes directly against both latent and lytic viral antigens [19, 20]. Accordingly, this study showed that EBV association with NPC in the Middle East is congruous with other NPC endemic regions and provide evidence that EBV is one of the most influential risk factors for the development of NPC in this region.
There was no age distinction for each type of HNCA. The mean age of the studied HNCA groups was higher than 50 years. This revealed that age of more than 50 years could be considered as a risk factor for HNCA development. Interestingly, higher level of EBV serum IgA but not IgG was found in NPC patients who were younger than the median age cutoff line, 54.4 years. This finding showed that older NPC patients were affected less by EBV as a risk factor of NPC development. This might give a clue that the high burden of EBV infection could accelerate the occurrence of NPC in the population and this is supported by a previous report  stating that the mean age of NPC patients in South East Asia is lower than in Western countries. This might be explained by the context of our results that EBV is a leading risk factor in high endemic regions of NPC like South East Asia and the Middle East which might accelerate NPC incidence making the mean age of NPC patients in high endemic regions less than that in western countries where EBV is less frequently associated with NPC. However, it is not clear why EBV serum IgG antibodies were not associated with younger NPC patients like IgA antibodies. One of the possible explanations, the older NPC patients might undergo severe immune suppression which affects the IgA antibodies more than the long-lasting IgG antibodies. However, this might need further investigation in a separate study to focus on this point of the research. Nevertheless, because EBV serum IgA antibodies are more specific than IgG antibodies in respect to NPC development, the association of EBV serum IgA antibodies with younger NPC patients was an interesting finding.
Male: female ratio in HNCA patients was 2.6:1 which reflected a male predominance over females. Many reports have confirmed this outcome and revealed that under 45 years of age the incidence in men was double that in women, with the increasing age the rate of incidence increase accelerated more in men than in women [21, 22]. HNCA groups showed different sex ratios. The male predominance in CL and NPC belongs largely to the nature of the risk factors in the Middle East society which affects males more than females. Men are more apt to be exposed to different risk factors due to the outdoor nature of work that most females in this region are not actively involved in. Therefore, most females, especially in the rural areas do house keeping jobs where less chances of exposure to pollution, occupational factors, passive smoking in the public regions, stress-induced immune suppression that help trigger EBV reactivation. Nevertheless, most HPC patients were females. It is worth mentioning that there was no previous report revealed female predominance in HPC patients like what found in this study. This needs further investigation to elucidate the reasons of this peculiar sex ratio in HPC patients in this region of the world.
The histopathology of NPC patients in this study was extensively different from that of other HNCA patients. The highly undifferentiated carcinoma, namely LE was dominant in NPC patients rather than SCC which was dominant in other HNCA groups. This attracts attention to the unique profile of risk/triggering factors of NPC which lead to different profiles of histopathology. In addition, the serum level of EBV IgG and IgA antibodies was significantly higher in LE group than SCC group of NPC patients confirming the principal role of EBV in the etiology of NPC especially the undifferentiated LE type of NPC. There is a study  stated that EBV is associated virtually with all cases of undifferentiated NPC, lymphoepithelioma, and has been classified as group I carcinogen. Therefore, the exclusive high percentage of LE tumors in NPC patients together with the unusual high levels of EBV serum IgG and IgA in NPC versus other HNCA groups and in LE group versus SCC group of NPC patients have led to the suggestion that EBV in the Middle East, or might be in any other high endemic region, plays a central role in the NPC development favoring LE histology on other types of HNCA histology.
In this study, smoking proved to be an important risk factor for the development of HNCA. The number of regular smokers among HNCA patients was much higher than in control group. Such results have been recorded in other parts of the world. A prospective study in the USA showed that heavy smokers die due to carcinoma of larynx 32 folds than age-adjusted non-smokers, and of oral cavity cancer, more than 24 folds . Nevertheless, this report stated a bit different results of our study which revealed that the rank of the highest numbers of regular smoker was in NPC, CL, and then HPC patients. Therefore, smoking seems much more effective in the etiology of NPC in the Middle East patients than in the patients of other parts of the world. In addition, the EBV serum level of both IgG and IgA antibodies was significantly higher in the regular smokers group of NPC than in the non-regular smoker group. This referred to a possible link between smoking and EBV in respect to NPC etiology or propagation. These findings together indicate that NPC is largely affected by smoking habit which is associated significantly with higher EBV serum antibodies and this point out to the possibility that cigarette smoke components are one of the initiative factors for EBV reactivation within nasopharyngeal mucosa. This needs further investigation to dig deep. Once the relationship between EBV-induced NPC and smoking could be confirmed, this will open new measures for NPC epidemiology and prevention.
Unlike smoking habit, the percentage of regular alcohol consumers in HNCA patients was not significantly higher than in control group, except for NPC patients who showed a remarkable higher percentage of regular alcohol consumers than control subjects and other HNCA patients. This provided evidence that alcohol intake could acts as one of the important risk factors of NPC development. And this affection was not seen in other HNCA types making alcohol intake of particular significance to NPC patients. This finding is supported by a previous report showed that excessive alcohol consumption increases the risk of incurring cancers of oral cavity, pharynx and to a lower extent larynx . Anyhow, our study did not reveal a significant association of alcohol intake with CL as shown by . Unlike smoking, this study revealed no association between alcohol intake and EBV in NPC patients which might indicate that alcohol intake is an EBV-independent risk factor for the development of NPC. Hence, another factor might be associated with alcohol intake in respect to NPC development rather than EBV. It was found that the dominant histology in the regular alcohol consumers group of NPC was SCC while in the non-regular alcohol consumers group was LE. This finding gave a clue that alcohol could affect NPC development away from EBV effect which was significantly related to LE histology. Accordingly, it was proposed that alcohol intake might be the most influential risk factor of SCC tumors but not LE tumors of NPC. In other words, alcohol intake might be the most important risk factor of NPC development out of the indirect effect of EBV infection.
Cancer is a disease of multifactorial etiology involving environmental and genetic factors. The genetic susceptibility is best measured by the family history of the disease [24, 25]. In this study, NPC patients showed the lowest percentage of positive family history of the disease among HNCA. Statistical analysis clarified that NPC group was associated significantly with the negative family history of the disease while other HNCA groups were associated significantly with the positive family history of the disease. This implies to the notion that the environmental risk factors most probably play more important role in the etiology of NPC than the familial genetic factors. Moreover, the positive family history group of NPC showed far lower levels of serum EBV IgG and IgA antibodies than negative family history group. These findings together referred to many points to discuss. First, NPC is most affected by environmental than genetic factors. Second, patients with genetically predisposed NPC are unlikely associated with EBV as a risk or predisposing factor. Third, EBV etiology of NPC patients is less likely affected by familial and inheritable susceptibility and it acts as an independent risk factor. Therefore, it was proposed that the familial carcinogenic background of NPC patients might not be so essential for it's etiology like in CL and HPC suggesting that the biological and environmental risk factors are dominant over the genetic factors for NPC development.
NPC is often difficult to be diagnosed because of the non-specific nature of its clinical symptoms and the difficulty in visualizing the nasopharynx . Most of NPC tumors remain undiagnosed until metastasis to the cervical lymph nodes occurs, often without overt pathology at the primary site [27, 28] which indicates the desperate need for an early diagnosis and early treatment strategies to improve survival. Early detection of NPC should improve cure rate and reduce morbidity and metastasis. Taking into account the high incidence of NPC in many regions of the world and its difficult early diagnosis, hence the determination of the correct high risk groups of NPC in every society seems invaluable and life saving. EBV serological screening assays might be one of the reliable means for the population screening of NPC.
Taken together, NPC showed a particular profile of risk factors that deviate much from other HNCA groups. NPC was particularly affected and triggered/promoted by EBV, LE tumors, alcohol intake, smoking habit, male patients. Unlike other studied HNCA groups, NPC was not affected much by HNCA-positive family history. On the other hand, the risk factors influence the development of other HNCA patients were smoking, increased age, male patients for CL and female patients for HPC, positive family history, and SCC tumors. Interestingly, this study also showed that higher levels of serum EBV IgG and IgA antibodies in NPC patients were associated with HNCA-negative family history, regular smoker group of NPC, LE histology of NPC, and younger NPC patients. In contrast, EBV serum antibodies were not associated with regular alcohol consumers or the sex of NPC patients. Hence, smoking and LE histology in NPC group might act as dependent risk factors via reactivating EBV infection. In contrast, alcohol consumption was associated with SCC tumor of NPC rather than higher levels of serum EBV IgG antibodies indicating that alcohol consumption is an EBV-independent risk factor for the development of NPC mainly of SCC histology. In addition, EBV risk factor might hasten the incidence of NPC patients in younger age. This study clarified the central role of EBV in controlling other risk factors of NPC making this disease distinct in terms of risk factors profile and incidence distribution. In addition, it is thought that a screening test for measuring the serum level of EBV IgA and IgG antibodies in the correctly determined high risk groups of a population will help much establish the correct basis for the early diagnosis and proper treatment of NPC patients.
This study was perpetuated and supported by Univerity Putra Malysia (UPM) where all facilities were provided to conduct this study. Special appreciation for the staff of the hospital centers in the Middle East where patient's interview and sampling was carried out.
- Erkal HS, Serin M, Cakmak A: Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome. Radiother Oncol. 2001, 61 (3): 247-56. 10.1016/S0167-8140(01)00448-0.View ArticlePubMedGoogle Scholar
- Cooper JS, Lee H, Torrey M, Hochster H: Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: preliminary corroboration of the intergroup experience. Int J Radiat Oncol Biol Phys. 2000, 47 (4): 861-6.View ArticlePubMedGoogle Scholar
- Burt RD, Vaughan TL, McKnight B: Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States. Int J Cancer. 1992, 52 (4): 549-56. 10.1002/ijc.2910520409.View ArticlePubMedGoogle Scholar
- Yu MC, Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002, 12 (6): 421-9. 10.1016/S1044579X02000858.View ArticlePubMedGoogle Scholar
- Busson P, Ooka T, Corbex M: Nasopharyngeal carcinomas and Epstein-Barr virus: from epidemiology and detection to therapy. Med Sci (paris). 2004, 20 (4): 453-7.View ArticleGoogle Scholar
- Ou SH, Zell JA, Ziogas A, Anton-Culver H: Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology. Ann Oncol. 2007, 18 (1): 29-35. 10.1093/annonc/mdl320.View ArticlePubMedGoogle Scholar
- Ng WT, Choi CW, Lee MC, Chan SH, Yau TK, Lee AW: Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening. Fam Cancer. 2008Google Scholar
- Akeshita H, Furukawa M, Fujieda S, Shoujaku H, Ookura T, Sakaguchi M, Ito H, Mineta H, Harada T, Matsuura H: Epidemiological research into nasopharyngeal carcinoma in the Chubu region of Japan. Auris Nasus Larynx. 1999, 26 (3): 277-86. 10.1016/S0385-8146(98)00080-7.View ArticleGoogle Scholar
- Iraqi cancer Board: Annual Iraqi cancer registry bulletin. 2003Google Scholar
- Tang JG, Li Xuan, Cheng P: Expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection. J Zhejiang Univ SCI. 2004, 5 (10): 1304-1312. 10.1631/jzus.2004.1304.View ArticlePubMedPubMed CentralGoogle Scholar
- Serraino D, Piselli P, Angeletti C, Scuderi M, Ippolito G, Capobianchi MR: Infection with Epstein-Barr virus and cancer: an epidemiological review. J Biol Regul Homeost Agents. 2005, 19 (1–2): 63-70.PubMedGoogle Scholar
- Pattle SB, Farrell PJ: The role of Epstein-Barr virus in cancer. Expert Opin Biol Ther. 2006, 6 (11): 1193-205. 10.1517/147125188.8.131.523.View ArticlePubMedGoogle Scholar
- Baumforth KR, Young LS, Flavell KJ, Constandinou C, Murray PG: The Epstein-Barr virus and its association with human cancers. Mol Pathol. 1999, 52 (6): 307-322. 10.1136/mp.52.6.307.View ArticlePubMedPubMed CentralGoogle Scholar
- UICC: TNM Classification of Malignant Tumors. 1978, 3Google Scholar
- Wakabayashi I, Kobaba-Wakabayashi R, Masuda H: Relation of drinking alcohol to atherosclerotic risk in type 2 diabetes. Diabetes Care. 2002, 25 (7): 1223-1228. 10.2337/diacare.25.7.1223.View ArticlePubMedGoogle Scholar
- Schuurs A, Weeman V: Enzyme innunoassay. Clin Chem Acta. 1977, 31 (4): 1-40. 10.1016/0009-8981(77)90410-7.View ArticleGoogle Scholar
- Cheng WM, Chan KH, Chen HL, Luo RX, Ng SP, Luk W, Zheng BJ, Ji MF, Liang JS, Sham JS, et al: Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int J Cancer. 2002, 97 (4): 489-492. 10.1002/ijc.1641.View ArticlePubMedGoogle Scholar
- Koshiol J, Qiao YL, Mark SD, Dawsey SM, Abnet CC, Kamangar F, Lennette ET, Dong ZW, Taylor PR: Epstein-Barr virus serology and gastric cancer incidence and survival. Br J Cancer. 2007, 97 (11): 1567-1569. 10.1038/sj.bjc.6604063.View ArticlePubMedPubMed CentralGoogle Scholar
- Fachiroh J, Schouten T, Hariwiyanto B, Paramita DK, Harijadi A, Haryana SM, Ng MH, Middeldorp JM: Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. J Infect Dis. 2004, 190 (1): 53-62. 10.1086/421245.View ArticlePubMedGoogle Scholar
- Chan KH, Gu YL, Ng F, Ng PS, Seto WH, Sham JS, Chua D, Wei W, Chen YL, Luk W, et al: EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer. 2003, 105 (5): 706-709. 10.1002/ijc.11130.View ArticlePubMedGoogle Scholar
- Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S: Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res. 1998, 18 (6B): 4779-4786.PubMedGoogle Scholar
- Young LS, Murray PG: Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 2003, 22 (33): 5108-5121. 10.1038/sj.onc.1206556.View ArticlePubMedGoogle Scholar
- Berrino F, Gatta G: Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. Eur J Cancer. 1998, 34 (14): 2154-2161. 10.1016/S0959-8049(98)00328-1.View ArticlePubMedGoogle Scholar
- Terrell JE, Nanavati K, Esclamado RM, Bradford CR, Wolf GT: Health impact of head and neck cancer. Otolaryngol-Head-Neck-Surg. 1999, 120 (6): 852-9. 10.1016/S0194-5998(99)70326-8.View ArticlePubMedGoogle Scholar
- Chang ET, Adami HO: The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006, 15 (10): 1765-1777. 10.1158/1055-9965.EPI-06-0353.View ArticlePubMedGoogle Scholar
- ong YS, Sham JS, Ng MH, Ou XT, Guo YQ, Zheng SA, Liang JS, Qiu H: Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer. 1992, 69 (1): 3-7. 10.1002/1097-0142(19920101)69:1<3::AID-CNCR2820690104>3.0.CO;2-7.View ArticleGoogle Scholar
- Feinmesser R, Miyazaki I, Cheung R, Freeman JL, Noyek AM, Dosch HM: Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med. 1992, 326 (1): 17-21.View ArticlePubMedGoogle Scholar
- Zheng H, Li LL, Hu DS, Deng XY, Cao Y: Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol. 2007, 4 (3): 185-196.PubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/8/400/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.